ArticleMolecular diversity2025

A practical synthesis of YZD-7082B, a novel orally bioavailable selective estrogen receptor degrader (SERD) for the treatment of ER+ breast cancer.

Yongqi He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.